Posts Tagged by harris communications
|November 25, 2013||Posted by Anharris under Innovation, Life Science|
At the event, Boston area startups Cocoon Biotech, Riparian Pharmaceuticals, Cellanyx Diagnostics, and DavosPharma were awarded $22K in funds and in-kind services to three Boston area life science companies.
The winners were chosen by Executives from EMD Serono, Novartis Institutes for BioMedical Research and LabCentral from among pitches delivered by five finalists. The five were selected from an initial field of thirteen online entries based, in part, on online feedback from BiotechTuesday members. The three winners were all therapeutics and diagnostics startups proposing solutions to challenging medical problems.
Cocoon Biotech, Inc., led by CEO and founder Ailis Tweed-Kent, a doctor at Massachusetts General Hospital won the $5000 EMD Serono Innovation Award. Cocoon Biotech is developing a silk-based gel for injection into the joint to provide long lasting joint support and lubrication in patients with osteoarthritis. EMD Serono is the biopharmaceutical subsidiary of Merck KGaA, Darmstadt, Germany, a global pharmaceutical and chemical group.
Riparian Pharmaceuticals, led by Will Adam, Chief Scientific Officer and President, won both the $10,000 in-kind Novartis Innovation Award and the $3000 in-kind Pharmatek Innovation Award. Riparian Pharmaceuticals is focused on therapeutics that induce an anti-inflammatory response in cells to address diseases such as atherosclerosis. Novartis Institutes for BioMedical Research, Inc. discovers and develops new and innovative medicines. Pharmatek Laboratories, Inc. is a premier pharmaceutical chemistry development and manufacturing organization supporting the pharmaceutical & biotechnology industries.
Anharris | Harris Communications GroupAnharris | Harris Communications GroupCellanyx Diagnostics, led by Co-Founder and CEO Ashok Chander, won the $4000 in-kind LabCentral Innovation Award. Cellanyx is developing a prostate cancer diagnostic based on culturing tumor biopsy cells that promises to be much more accurate than current diagnostics. LabCentral provides fully functional lab space, permits, waste handling, plus all reasonably common lab equipment for bioresearch.
In addition to awarding startups, the event also acknowledged the contribution of life science products and services in enabling cutting edge research for new therapeutics. DavosPharma won the Most Innovative Product or Service Award in recognition of its Anthem-GenTox product. This product offers scientists a high throughput genotoxicity assay based on human cells with greatly improved accuracy over conventional methods.
Full disclosure: Biotech Tuesday co-founder Seth Taylor serves on our advisory board.
Anita Harris is president of the Harris Communications Group, an award-winning PR firm specializing in strategy, content, media relations for clients in health, science, technology and energy.
|November 6, 2013||Posted by Anharris under Events|
Pleased to have attended the celebration for the opening of District Hall–the beautiful new event center for innovators located in Boston’s snazzy Seaport District–just across from the Institute for Contemporary Art. Managed by the Venture Cafe Foundation–a sister organization of the Cambridge Innovation Center (C)C) where I work– District Hall has a large event space, conference and class rooms, a restaurant and a view of the Harbor. What I like best is its scale–it’s not a skyscraper, is not overwhelming like the nearby convention center or the CIC in Kendall Square. It’s just a simple, welcoming space with white board, galore.
As described on its Web site as:
“It’s the first building of its kind in the world….
” …A dedicated civic space where the innovation community can gather and exchange ideas. Inside you’ll find open workspace, classrooms, assembly space, flexible use ‘pods’, and writable surfaces everywhere! Also stop by for coffee and food at Brew and Gather.”
“…The result of a collaborative public-private partnership. When Mayor Thomas M. Menino announced his vision for the Innovation District, he called for a gathering space for innovators to get together and share ideas. The building was then privately funded and built by Boston Global Investors, as the first project in their twenty-three acre masterplan for Seaport Square. Operations and programming are run by the Venture Café Foundation, a not-for-profit sister organization to the Cambridge Innovation Center (CIC). ”
75 Northern AvenueBoston, MA. 02210
—Anita M.Harris, Managing Director
Harris Communications Group
The Harris Communications Group is an award-winning PR and market development firm. Based in Kendall Square, Cambridge, MA, we provide a media relations, marketing communications, writing, crisis communications, content, marketing and social media services for companies in health, science, technology and energy.
|June 23, 2012||Posted by Anharris under Health, Innovation, Life Science, Technology|
Had a great time at the BIO International Convention in Boston, last week. Met teams from Norway, Australia, France, India, Israel…not to mention New York, North Carolina, Maryland, Oklahoma, etc.
Attendance, at 15,000, was down from its 25,000 high here five years ago but I found participants friendly and accessible. HarrisCom advisor Christa Bleyleban said she counted more than 70 parties or networking gatherings (not a few of which I attended).
While the overall theme was” innovation,” it was a trend toward collaboration that I noticed most.
- Cancer collaboration clusters in Oslo, Toulouse, the UK and Massachusetts were showcased at a program sponsored by the Massachusetts Technology Transfer Center, on Sunday.
- A collaboration between four Massachusetts and four Israeli companies was announced on Tuesday
- Collaborations between Massachusetts and Catalonia, in Spain, and between Massachusetts and Medicon Valley, in Sweden and Denmark, were announced on Wednesday.
- Also on Wednesday came the announcement that seven global companies have joined forces to fund preclinical neuroscience research in Massachusetts universities. While the funding is a paltry $2–the announcement will come as good news for scientists seeking early stage funding–but heightens concerns that industry will waylay– or have too much power in setting agendas for– basic research.
At a meeting sponsored by Polaris Ventures, industry execs and VCs discussed the shift of VC funds from biotech to the tech sector–which is occurring in part because tech investments can lead to quicker returns. One observer commented that pharma companies themselves are the new VCs–investing in early stage research rather than doing the research themselves.
In that regard, I partnered with the Communications Strategy Group on a press conference and outreach in which the Swiss company AC Immune announced a $400M licensing agreement with Genentech for development of an antibody to combat Alzheimer’s disease.
Also of interest was a keynote talk, sponsored by Scientific American, in which CNN’s Fareed Zakariah asked whether the US will continue to maintain its lead in technologic innovation.
For more details, please visit my postings at New Cambridge Observer.
–Anita M. Harris
Anita Harris is President of the Harris Communications Group, an award-winning PR, marketing and communications firm headquartered in Cambridge, MA.
|June 6, 2012||Posted by Anharris under Cool Companies, Health, Innovation, Life Science|
Met the other day with Rob Johnson, who will soon be launching UK-based Alacrita, a global life science consulting firm, to Cambridge, MA.
Johnson co-founded the company two years ago with Anthony Walker, who had previously served as Executive Director of Global External R&D Europe at Eli Lilly. Johnson had led business development at Onyvax, a biotech company that developed biopharmaceuticals to combat cancer.
Drawing on the capabilities of more than 50 consultants worldwide, Alacrita provides strategic, operational, technical advice or hands-on project management to organizations of all sizes in the pharma, biotechnology and life science industries, Johnson said.
The company name is based the Latin, “alacritas,” or “lively.”It is meant to convey “a cheerful readiness.”
Clients may be academic institutes, tech transfer experts, life science investors, startups or established companies in need of expertise in business development and marketing, intellectual property, product development, and regulatory affairs, according to Johnson.
Whitepapers available for free on Alacrita’s Web site include:
- Biotech in Israel: A Land of Promise » May 2012 – by Anthony Walker, PhD
- FDA Approvals Provide Reason For Cheer » March 2012 – by Robert Johnson
- Deal Watch Annual Review 2011 » January 2012
- Viewpoint: Pharma Industry Myths » January 2012 – by Anthony Walker, PhD
- Europe’s stellar decade of prostate cancer innovation » September 2011 – by Rob Johnson
- Are we all biotech now? » June 2011 – by Anthony Walker and Rob Johnson
- China: Opportunities for biotech firms » March 2011 – by Rob Johnson and Li Zeng
- Re-Profiling: a Hidden Threat to Originators? » February 2011 – by Dr Jo Davies
- Deal Watch Annual Review 2010 » January 2011 – by Roger Davies and Jill Ogden
- Mitigating Out-sourcing Risk » December 2010 – by Robert Johnson and Anthony Walker
- Deal Watch: a Review of Notable Deals » October 2010 – by Sharon Finch
Alacrita’s US offices will be located in the Cambridge Innovation Center in Kendall Square, Johnson said.
–Anita M. Harris
Anita Harris is president of the Harris Communications Group, a strategic PR & marketing communications firm located in Cambridge, MA.
|December 8, 2011||Posted by Anharris under Communications, Content Strategy, New Media, SEO, Web design|
Hubspot’s SEO Scientist Dan Zarrella definitely caught my attention when he asked in a recent Webinar if search is dead. He concluded that it is not–but that there’s no point in hiring SEO (search engine optimization) experts to game search engine algorithms to up your rankings on the Web. His words, “What you really need are content production people “, were music to my content-strategist ears.
In “The Science of SEO” (Dec. 8, 2011), Zarrella outlined new research suggesting that while high search engine rankings can make your site seem more trustworthy, people under 30 are aware that many of the highest ranking sites are paid–and most people surveyed did not trust pay for click sites or admit to clicking on them.
This means that the key to optimal search engine placement is “organic” search–in which “spiders” electronically find and rank sites based on the usefulness of their content, he said. That usefulness is determined mainly by the numbers of links connecting a site from other sites. |
How can you get more links? Zarrella advises:
-Post “piles and piles” of content: a blog or more a day
-Keep titles to 40-80 characters–tweet length–so that your content can be readily picked up by social media users
-Write on newsworthy, timely topics
-Post early in the week and early in the day–which is when bloggers are looking for news to cover/link to.
-Don’t use buzzwords or jargon
-Bear in mind photos and video on sites encourage links–and that, according to Zarrella’s research, videos are linked-to far more often than are photos.
Zarrella said he can’t explain why that should be but “it shows there are many different kinds of search engines and they are all looking for content.”
The Webinar is available for free at http://www.hubspot.com/the-science-of-seo/.